Health Catalyst Inc [HCAT] stock prices are up 7.39% to $8.86 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The HCAT shares have gain 14.03% over the last week, with a monthly amount glided 12.01%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Health Catalyst Inc [NASDAQ: HCAT] stock has seen the most recent analyst activity on April 10, 2024, when KeyBanc Capital Markets downgraded its rating to a Sector Weight. Previously, Evercore ISI upgraded its rating to Outperform on January 03, 2024, and kept the price target unchanged to $11. On January 03, 2024, Barclays initiated with a Overweight rating and assigned a price target of $14 on the stock. JP Morgan upgraded its rating to a Overweight and decreased its price target to $11 on December 13, 2023. Piper Sandler upgraded its rating to a Overweight and reduced its price target to $11 on November 13, 2023. Cantor Fitzgerald started tracking with a Overweight rating for this stock on August 01, 2023, and assigned it a price target of $16. In a note dated May 10, 2023, Raymond James downgraded an Mkt Perform rating on this stock.
The stock price of Health Catalyst Inc [HCAT] has been fluctuating between $5.42 and $11.41 over the past year. Currently, Wall Street analysts expect the stock to reach $29.25 within the next 12 months. Health Catalyst Inc [NASDAQ: HCAT] shares were valued at $8.86 at the most recent close of the market. An investor can expect a potential return of 230.14% based on the average HCAT price forecast.
Analyzing the HCAT fundamentals
The Health Catalyst Inc [NASDAQ:HCAT] reported sales of 302.06M for trailing twelve months, representing a surge of 3.50%. Gross Profit Margin for this corporation currently stands at 0.36% with Operating Profit Margin at -0.21%, Pretax Profit Margin comes in at -0.26%, and Net Profit Margin reading is -0.26%. To continue investigating profitability, this company’s Return on Assets is posted at -0.1, Equity is -0.22 and Total Capital is -0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.97 points at the first support level, and at 7.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.40, and for the 2nd resistance point, it is at 9.93.
Ratios To Look Out For
It’s worth pointing out that Health Catalyst Inc [NASDAQ:HCAT]’s Current Ratio is 1.41. Also, the Quick Ratio is 1.18, while the Cash Ratio stands at 1.01. Considering the valuation of this stock, the price to sales ratio is 1.77, the price to book ratio is 1.52.
Transactions by insiders
Recent insider trading involved LeSueur Daniel, Chief Operating Officer, that happened on Nov 05 ’24 when 5209.0 shares were sold. Officer, DANIEL LESUEUR completed a deal on Nov 05 ’24 to buy 5209.0 shares. Meanwhile, Chief People Officer Llewelyn Linda sold 1324.0 shares on Oct 15 ’24.
